GlaxoSmithKline Plc (GSK: Quote,GSK.L) said it has extended its tender offer to buy all of the outstanding shares of Human Genome Sciences (HGSI: Quote) for $13.00 per share in cash to 5:00 p.m. New York City time on June 29, 2012.
The tender offer was earlier scheduled to expire at 12:00 midnight New York City time, at the end of the day on June 7, 2012.
GSK's offer represents a premium of 81 percent to Human Genome Sciences' closing share price of $7.17 on April 18, 2012, the last trading day before Human Genome Sciences publicly disclosed GSK's private offer. GSK continues to believe its offer represents full and fair value and is in the best interests of both companies' shareholders.
Click here to receive FREE breaking news email alerts for GlaxoSmithKline PLC and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org